News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 06, 2016, 06:00 ET

United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United...

Oct 27, 2015, 06:00 ET

United Therapeutics Corporation Reports Third Quarter 2015 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2015. "We...

Oct 21, 2015, 06:00 ET

United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2015 financial results before market...

Oct 15, 2015, 06:00 ET

United Therapeutics Announces Additional $500 Million Share Repurchase Program

 United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional...

Sep 30, 2015, 06:00 ET

United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz Inc. ("Sandoz")...

Aug 19, 2015, 06:00 ET

United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease...

Aug 17, 2015, 06:00 ET

European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for...

Aug 06, 2015, 06:00 ET

United Therapeutics Corporation To Present At The 2015 Wedbush PacGrow Healthcare Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of...

Jul 28, 2015, 06:00 ET

United Therapeutics Corporation Reports Second Quarter 2015 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30,...

Jul 22, 2015, 06:00 ET

United Therapeutics Corporation To Announce Second Quarter 2015 Financial Results Before Market Open On Tuesday, July 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2015 financial results before market open on...

Jun 29, 2015, 06:00 ET

Dean Judy D. Olian Joins the United Therapeutics Corporation Board of Directors

 United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an...

Jun 15, 2015, 09:00 ET

United Therapeutics Corporation Receives Paragraph IV Notice Letter for Tyvaso

 United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories,...

May 29, 2015, 06:00 ET

United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...

May 01, 2015, 06:00 ET

United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United...

Apr 28, 2015, 06:00 ET

United Therapeutics Corporation Reports First Quarter 2015 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total...

Apr 21, 2015, 06:00 ET

United Therapeutics Corporation To Announce First Quarter 2015 Financial Results Before Market Open On Tuesday, April 28, 2015

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on...

Mar 10, 2015, 11:18 ET

United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin™ for Pediatric High-Risk Neuroblastoma

United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics...

Mar 10, 2015, 11:12 ET

FDA Approves Unituxin™ (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...

Feb 25, 2015, 06:00 ET

United Therapeutics Corporation To Present At The Cowen And Company 35th Annual Healthcare Conference

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United...

Feb 24, 2015, 06:00 ET

United Therapeutics Corporation Reports 2014 Fourth Quarter And Annual Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31,...